BioLizard
Board
2 directors, 1 in day-to-day management, no change since 2024NOVALIS GENERAL PARTNERS
Director
since 26-11-2019
listed in the 2025 annual accounts, filed on 03-07-2026
Effra Consult Ltd
Director, permanent representative Caroline Vanovermeire
appointed by deed of 22-10-2024
listed in the 2025 annual accounts, filed on 03-07-2026
Ceelen Consultancy Comm.V
Persoon belast met het dagelijks bestuur,genaamd chief executive officer ofwel ceo, permanent representative Liesbeth Ceelen
appointed by deed of 05-01-2023
term without a fixed end
- Ceelen Consultancy
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “De vennootschap wordt in al haar handelingen, met inbegrip van de vertegenwoordiging in rechte, rechtsgeldig vertegenwoordigd door twee…”deed of 28-11-2018
Permanent representatives 2
Caroline Vanovermeire
Permanent representative, for Effra Consult Ltd
appointed by deed of 22-10-2024
Mandates through the years
6 names, the dashed line is todayNOVALIS GENERAL PARTNERS
Director
Director
Effra Consult Ltd
Director
Director
Ceelen Consultancy
Persoon belast met het dagelijks bestuur,genaamd chief executive officer ofwel ceo
Persoon belast met het dagelijks bestuur,genaamd chief executive officer ofwel ceo
NOROMID
Director
Director
MENSCHAERT Gerben Clement Angèle
Director
Director
Novalis
Managing director and chair of the board
Managing director and chair of the board
LeadershipBoardEarliermandate already running before its first mentionend not dated
Mandates as a list
- NOVALIS GENERAL PARTNERS
- Director, from 26-11-2019 to date
- Effra Consult Ltd
- Director, appointed by deed of 22-10-2024, still in office
- Ceelen Consultancy
- Persoon belast met het dagelijks bestuur,genaamd chief executive officer ofwel ceo, since before 31-12-2022
- NOROMID
- Director, appointed by deed of 21-06-2019, until 22-10-2024
- MENSCHAERT Gerben Clement Angèle
- Director, appointed by deed of 28-11-2018, until 21-06-2019
- Novalis
- Director, appointed by deed of 28-11-2018, last mentioned in 2018
- Managing director and chair of the board, appointed by deed of 28-11-2018, last mentioned in 2018
Control
93%
This company
BioLizard
Equity €3.7m
Profit €324,234 in 2025
Capital
- Capital
- €466,664
- Source
- deed of 09-09-2020
Owners through the years
as the annual accounts name themOwners as a list
Source: parent in its own accounts, lists of holdings in the owners' accounts
Articles of association
deed of 28-11-2018 (in Dutch)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directors
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 17:00
Capital transactions
Shareholders according to the deeds
After the capital increase
deed of 09-09-2020 ↗
- NOVALIS 744 shares
- Gerben Menschaert 32 shares
- Liesbeth Ceelen 24 shares
Capital over time
- 09-09-2020 Capital increase of €266,664 · to €466,664 · 800 new shares · in cash